Gorrection of nutritional status violations by a diet in patiets on maintenance hemodialysis with and without diabetes type 2


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Protein-energy wasting (PEW) is widespread condition among patients receiving maintenance hemodialysis (MH). A serious destabilizing factor in nutritional status is insulin resistance and chronic inflammation, which are especially pronounced in the presence of diabetes mellitus in addition to chronic kidney disease. Given that type 2 diabetes mellitus (T2DM) has become one of the leading causes of end-stage chronic kidney disease (ESRD), it is especially important to develop an effective strategy to resist the progression of protein depletion and ensure better survival and quality of life in such patients. We believe that identifying inadequate intake of essential nutrients and calories, dietary counseling and diet correction can make a noticeable beneficial effect on nutritional status and the degree of chronic inflammation in patients with PEW, including those with T2DM. The aim of the study. To assess the efficacy of diet therapy in the correction of metabolic disorders based on a comprehensive assessment of the nutritional status and dynamics of chronic inflammation biomarkers in patients with CKD and T2DM on MH. Material and methods. The study involved 79 patients (mean age 62.0±11 years), with an average duration of MH 10.0±5.4 years. Patients were divided into 2 groups: with T2DM (T2DM+, n=40) and without T2DM (T2DM-, n=39). In both groups, an analysis of the nutritional status of patients was carried out (using physical, laboratory and instrumental parameters), the data of protein, fat and carbohydrates dietary intake were collected and analyzed on the basis of food diaries. All patients were prescribed an individual corrective diet in order to bring the parameters of the diet to those recommended for patients on MH, in the T2DM group - taking into account the compensation of hyperglycemia. Soy isolate was used as an additional source of complete protein. The dynamics of changes in indicators of nutritional status and chronic inflammation from baseline in both groups was monitored after 6 and 12 weeks of diet therapy. A comparative analysis of the dynamics of indicators between the groups was carried out. Results. PEW was 2 times more frequent in the group with T2DM - 26 (65%) patients; in the group without T2DM, PEW was diagnosed only in 11 (28%) patients. The initial bioimpedance data obtained indicated a more frequent presence in patients with T2DM of "sarcopenic obesity": reduced lean mass in the presence of increased body fat and increased waist circumference. The severity of chronic inflammation, according to the corresponding biomarkers (interleukines 1 and 6, advanced glycation endproducts, C-reactive protein) was also higher in the T2DM+ group. The diet of diabetic patients was poorer in all macronutrients and significantly lower in energy supply. After correcting the composition of the diet for macronutrients and calories, positive changes in some of the objective indicators of nutritional status and biomarkers of chronic inflammation were noted in both groups by the end of the study (12 weeks). These changes were more evident in the T2DM+ group. Conclusion. The presence of T2DM in patients with CKD on MH significantly aggravates the disturbances in nutritional status and increases the degree of chronic inflammation in comparison with patients without T2DM. Conducted adequate dietary therapy based on the obtained indicators of nutritional status and food diaries can reduce the degree of chronic inflammation and PEW in this category of patients.

Full Text

Restricted Access

About the authors

Svetlana Vladimirovna Tishkina

State Budget Healthcare Institution of Moscow Healthcare Department City Hospital n.a. N.I. Pirogov

Email: svet0810@gmail.com
nephrologist of 1-st

Nataliia Alexeevna Mikhailova

Federal State Budgetary Educational Institution of Further Professional Education Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare

Email: natmikhailova@mail.ru
PhD, associate professor

Andrey Mikhailovich Kartsev

State Budget Healthcare Institution of Moscow Healthcare Department City Hospital n.a. N.I. Pirogov

Email: esquera@mail.ru
PhD, nephrologist of 1-st

Anna Victorovna Tishkina

Pirogov Russian National Research Medical University

Email: anstille@gmail.com
resident physician

Anna Vyatcheslavovna Pushkina

«Fespharm» LLC

Email: avpushkina@yandex.ru
PhD, Head physician

Elena Alexandrovna Derinova

Federal State Institution National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthcare of the Russian Federation

Email: derinova_ea@mail.ru
PhD, senior teacher

References

  1. IDF Diabetes Atlas 2021. 10th edition. https://diabetesatlas.org/atlas/tenth-edition
  2. IDF Diabetes Atlas 2020. 9th edition. ISBN: 978-2-930229-87-4. https: atlas@ idf.org I. www.diabetesatlas.org
  3. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016;19(2):104-12. doi: 10.14341/DM2004116-17.
  4. Шестакова М.В., Викулова О.К., Железнякова А.В. и др. Эпидемиология сахарного диабета в Российской Федерации: что изменилось за последнее десятилетие? Терапевтический архив. 2019;10:4-13. doi: 10.26442/00403660.2019.10.000364.
  5. Дедов И.И., Калашникова М.Ф., Д.Ю. Белоусов и др. Анализ стоимости болезни сахарного диабета 2 типа в российской федерации: результаты российского многоцентрового наблюдательного фармако-эпидемиологического исследования Форсайт-СД2. Сахарный диабет. 2017;20(6):403-19. doi: 10.14341/DM9278.
  6. Ghaderian S.B., Hayati F., Shayanpour S., Beladi Mousavi S.S. Diabetes and endstage renal disease; a review article on new concepts. J. Ren. Inj. Prev. 2015;4:28e33.
  7. Бикбов Б.Т., Томилина Н.А. Состав больных и показатели качества лечения на заместительной терапии терминальной хронической почечной недостаточности в Российской Федерации в 1998-2013 гг. Отчет по данным регистра заместительной почечной терапии Российского Диализного Общества. Часть вторая. Нефрология и диализ 2016;18(2):98-164.
  8. Tancredi M., Rosengren A., Svensson A.-M., et al. Excess Mortality among Persons with Type 2 Diabetes. N. Engl. J. Med. 2015;373:1720-32.
  9. A/L. B. Vasanth Rao V.R., Tan S.H., Candasamy M., Bhattamisraet S.K. Diabetic nephropathy: An update on pathogenesis and drug development. Diab. Metab. Syndr.: Clin. Res. Rev. 2019;13:754-62. doi: 10.1016/j.dsx.2018.11.054.
  10. Nicholas D.A., Proctor E.A., Agrawal M., et al. Fatty acid metabolites combine with reduced /3-oxidation to activate Th17 inflammation in human Type 2 Diabetes. Cell. Metab. 2019;30:447-61. doi: 10.1016/j.cmet.2019.07.004.
  11. Brodeur M.R., Bouvet C., Bouchard S., et al., Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes. PLoS ONE. 2014;9(1):Article ID e85922.
  12. Dozio E., Vettoretti S., Caldiroli L., et al. Advanced glycation end products (AGE) and soluble forms of AGE receptor: emerging role as mortality riskfactors in CKD. Biomed. 2020;8:638. doi: 10.3390/biomedicines8120638.
  13. Rambod M., Bross R., Zitterkoph J., et.al. Association of malnutrition-inflammation score with quality of life and mortality in Hemodialysis Patients: a 5-year prospective cohort study. Am. J. Kidney Dis. 2009;53(2):298-309. doi: 10.1053/j.ajkd.2008.09.018.
  14. Lukowsky L.R., Kheifets L., Arah O.A., et al. Nutritional predictors of early mortality in incident hemodialysis patients. Int. Urol. Nephrol. 2014;46(1): 129-40. doi: 10.1007/s11255-013-0459-2.
  15. Ravel V.A., Molnar M.Z., Streja E., et al. Low protein nitrogen appearance as a surrogate of low dietary protein intake is associated with higher all-cause mortality in maintenance hemodialysis patients. J. Nutr. 2013;143(7):1084- 92. doi: 10.3945/jn.112.169722.
  16. Palmer S.C., Maggo J.K., Campbell K.L., et al. Dietary interventions for adults with chronic kidney disease. Cochrane Database Syst. Rev. 2017;;4(4):CD011998. doi: 10.1002/14651858.CD011998.pub2.
  17. Кучер А.Г., Каюков И.Г., Григорьева Н.Д., Васильев А.Н. Лечебное питание на различных стадиях хронической болезни почек. Нефрология и диализ 2007;9(2):118-35.
  18. Hanna R.M., Ghobryc L., Wasse O., et al. A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease. Blood Purif. 2727;19:272-11. doi: 17.1159/777571217.
  19. Sezer S., Bal Z., Tutal E., et al. Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis. JPEN. J. Parenter. Enteral. Nutr. 2014;38:960-65. doi: 10.1177/0148607113517266.
  20. Losappio V., Infante B., Leo S., et al. Nutrition-based management of inflammaging in CKD and renal replacement therapies. Nutri. 2021;13:267. doi: 10.3390/nu13010267.
  21. Fouque D., Kalantar-Zadeh K., Kopple J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391-98. doi: 10.1038/sj.ki.5002585.
  22. Михайлова Н.А., Тишкина С.В., Ермоленко В.М. и др. Особенности нутриционного статуса у пациентов с сахарным диабетом 2 типа, находящихся на программном гемодиализе. Нефрология и диализ 2020;22(2):189-97. doi: 10.28996/2618-9801-2020-2-189-197].
  23. Thomas M.C., Cooper M.E., Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat.Rev. Nephrol. 2016;12(2):73-81. doi: 10.1038/nrneph.2015.173.
  24. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diab. Res. Clin. Pract. 2005;67:3-21. doi: 10.1016/j.diabres.2004.09.004.
  25. Emery P. W. Protein Synthesis and Turnover, in Encyclopedia of Food Sciences and Nutrition (Second Edition). 2003. P. 4858-63. doi: 10.1016/B0-12-227055-X/00986-X.
  26. Raj DS, Adeniyi O., Lim VS. Amino acid and protein kinetics in renal failure: an integrated approach. Semin Nephrol 2006; 26:158-166, doi: 10.1016/j.semnephrol.2005.09.006.
  27. Raj D.S., Welbourne T., Dominic E.A., et al. Glutamine kinetics and protein turnover in end-stage renal disease. Am. J. Physiol. 2004;288:E37-46. doi: 10.1152/ajpendo.00240.2004.
  28. Lim V.S., Ikizler T.A., Raj D.S., Flanigan M.J. Does hemodialysis increase protein breakdown? Dissociation between whole-body amino acid turnover and regional muscle kinetics. J. Am. Soc. Nephrol. 2005;16:862-68. doi: 10.1681/ASN.2004080624.
  29. Raj D.S., Dominic E.A., Pai A., et al. Skeletal muscle, cytokines and oxidative stress in end-stage renal disease. Kidney Int. 2005;68:2338-44. doi: 17.1111/Q.1523-1755.2775.77695.x.
  30. Cheung W.W., Zheng R., Hao S., et al. The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia. Sci. Rep. 2021;11(1):15141. doi: 10.1038/s41598-021-94565-y.
  31. Thompson D., Walhin J.-P., Batterham A.M., et al. Effect of diet or diet plus physical activity versus usual care on inflammatory markers in patients with newly diagnosed type 2 diabetes: The Early ACTivity In Diabetes (ACTID) Randomized, Controlled Trial. J. Am. Heart Assoc. 2014;3:e000828. doi: 10.1161/JAHA.114.000828.
  32. Ojo O., Ojo O.O., Zand N., Wang X. The Effect of dietary fibre on gut microbiota, lipid profile, and inflammatory markers in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Nutr. 2021;13:1805. doi: 10.3390/nu13061805.
  33. Lacson E., Wang W., Zebrowski B. et al. Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: A quality improvement report. Am. J. Kidney Dis. 2012;60:591-600. doi: 10.1053/j.ajkd.2012.04.019.
  34. Benner D., Brunelli S.M., Brosch B., et al. Effects of oral nutritional supplements on mortality, missed dialysis treatments, and nutritional markers in hemodialysis patients. J. Ren. Nutr. 2018;28:191-96. doi: 10.1053/j.jrn.2017.10.002.
  35. Asemi Z., Soleimani A., Bahmani F., et al. Effect of the omega-3 fatty acid plus vitamin E. supplementation on subjective global assessment score, glucose metabolism, and lipid concentrations in chronic hemodialysis patients. Mol. Nutr. Food Res. 2016;60:390-98. doi: 10.1002/mnfr.201500584.
  36. Gharekhani A., Khatami M.R., Dashti-Khavidaki S., et al. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients. J. Ren. Nutr. 2014;24:177-85. doi: 10.1053/j.jrn.2014.01.014.
  37. Lou L.M., Campos B., Gimeno J.A., et al. Nutrient intake and eating habits in hemodialysis patients: comparison with a model based on mediterranean diet. Nefrol. 2007;27(1):38-45.
  38. Saglimbene V.M., Wong G., Craig J., C. et al. The Association of Mediterranean and DASH Diets with mortality in adults on hemodialysis: The DIET-HD Multinational Cohort Study. J. Am. Soc. Nephrol. 2018;29(6):1741-51. doi: 10.1681/ASN.2018010008.
  39. Ozdemir F.N., Akçay A., Elsurer R., et al. Interdialytic weight gain is less with the Mediterranean type of diet in hemodialysis patients. J. Ren. Nutr. 2005;15(4):371-76. doi: 10.1053/j.jrn.2005.07.006.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies